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Abstract
Liver sinusoidal endothelium is strategically positioned to control access of fluids, macromolecules and cells to the liver
parenchyma and to serve clearance functions upstream of the hepatocytes. While clearance of macromolecular debris from
the peripheral blood is performed by liver sinusoidal endothelial cells (LSECs) using a delicate endocytic receptor system
featuring stabilin-1 and -2, the mannose receptor and CD32b, vascular permeability and cell trafficking are controlled by
transcellular pores, i.e. the fenestrae, and by intercellular junctional complexes. In contrast to blood vascular and lymphatic
endothelial cells in other organs, the junctional complexes of LSECs have not yet been consistently characterized in
molecular terms. In a comprehensive analysis, we here show that LSECs express the typical proteins found in endothelial
adherens junctions (AJ), i.e. VE-cadherin as well as a-, b-, p120-catenin and plakoglobin. Tight junction (TJ) transmembrane
proteins typical of endothelial cells, i.e. claudin-5 and occludin, were not expressed by rat LSECs while heterogenous
immunreactivity for claudin-5 was detected in human LSECs. In contrast, junctional molecules preferentially associating with
TJ such as JAM-A, B and C and zonula occludens proteins ZO-1 and ZO-2 were readily detected in LSECs. Remarkably,
among the JAMs JAM-C was considerably over-expressed in LSECs as compared to lung microvascular endothelial cells. In
conclusion, we show here that LSECs form a special kind of mixed-type intercellular junctions characterized by co-
occurrence of endothelial AJ proteins, and of ZO-1 and -2, and JAMs. The distinct molecular architecture of the intercellular
junctional complexes of LSECs corroborates previous ultrastructural findings and provides the molecular basis for further
analyses of the endothelial barrier function of liver sinusoids under pathologic conditions ranging from hepatic
inflammation to formation of liver metastasis.
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Introduction
Liver sinusoidal endothelial cells (LSECs) form a fenestrated
monolayer at the inner side of the liver sinusoids constituting
a barrier between blood flow and hepatocytes facing the
perisinusoidal space of Disse [1,2,3]. Leukocyte recruitment upon
liver injury [4,5,6] as well as liver colonization by metastatic tumor
cells [7,8] are actively influenced by LSECs. The unique
morphology as well as the microenvironment-dependent molecular
differentiation of LSECs [19] define the organ-specific features of
this transendothelial barrier. Despite recent advances in un-
derstanding extravasation of inflammatory and tumor cells in liver
sinusoids [6], the intercellular junctions between LSECs that
considerably contribute to regulating hepatic transmigration have
not yet been sufficiently characterized in molecular terms.
The most remarkable morphological hallmark of LSECs is the
presence of fenestrae that are arranged in clusters being referred
to as sieve plates. The fenestrae of LSECs form open pores that
lack a diaphragm; they contribute substantially to the high
permeability of LSECs compared to other microvascular
endothelial cells [9,10,11]. Besides diffusion through the
fenestrae, LSECs actively support uptake and degradation as
well as transendothelial transfer of macromolecules by their high
endocytic capacity. Endocytic clearance of soluble macromole-
cules from the circulation is mediated by specialized endocytic
receptors [12] including the stabilins identified by us previously
[13,14]. The hepatic clearance function of LSECs is highly
important for the homeostasis of the whole organism protecting
distant organs such as the kidney from noxious blood factors
[14].
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of an ultrastructurally identifiable basement membrane. The
major molecular constituents of the vascular basal lamina in
general such as collagen IV, collagen VI, fibronectin, and tenascin
are detectable as amorphous material in the perisinusoidal space of
Disse [15]. LSECs correspondingly express a distinct repertoire of
integrins to interact with this extracellular matrix in the space of
Disse [15,16]. In line with this, we and others have shown that the
phenotype and functional activity of LSECs are strongly
influenced by the extracellular matrix and by the surrounding
hepatic cell populations such as Kupffer cells and hepatic stellate
cells with which LSECs intermingle in the wall of the liver
sinusoids [17,18,19].
Electron microscopy studies have identified junctional com-
plexes between cytoplasmic processes of adjacent LSECs; these
junctional complexes, however, did not precisely correspond to
typical adherens junctions (AJ) and even less so to typical tight
junctions (TJ) [20,21,22]. These findings were confirmed in vitro in
isolated human LSECs [23]. In line with these ultrastructural
ambiguities, it is still a matter of debate whether VE-cadherin
(Cdh5), the cadherin defining AJ in vascular endothelium, is
indeed expressed in LSECs. VE-cadherin was shown to be
expressed in LSECs of human embryos and fetuses during
antenatal development and the first postnatal week [16] as well
as in murine LSECs analyzed by FACS [24]. Others, however,
have reported that VE-cadherin was barely detectable in human
liver samples [25] and absent from isolated human LSECs [23].
Regarding TJ molecules, LSECs of nontumorous areas in
samples of human hepatocellular carcinoma were shown to
contain claudin-5, the typical transmembrane component of TJ
in vascular endothelium [26]. By contrast, vascular endothelial
junctional adhesion molecule (JAM-B/VE-JAM/JAM-2), a mem-
ber of the junctional adhesion molecule (JAM) family also
typically localizing to TJ could not be clearly detected in human
liver at the mRNA level [27,28]. In addition, mouse liver
sinusoids were found to be negative for JAM-C as revealed by
immunohistochemistry [29]. However, endothelial cell-selective
adhesion molecule (ESAM), a TJ molecule closely related to the
JAMs, was shown to be expressed in LSECs and to influence
leukocyte transmigration upon ischemia-reperfusion injury in the
liver [6]. As a consequence, the controversial findings regarding
the ultrastructure and the molecular composition of the
junctional complexes in LSECs have led Lalor and colleagues
to suggest that classical adherens and tight junctions are absent in
LSECs [30].
While the overall structure and molecular architecture of AJ
and TJ initially studied in epithelial tissues have been found to be
conserved in vascular endothelium, the particular organization of
TJ and AJ varies along the vascular tree and between blood
vascular and lymphatic endothelium [31]. Recent studies have
identified tissue-specific forms of intercellular junctions, among
these mixed-type junctions containing molecular components of
both AJ and TJ [32]. The endothelial cells of the initial
lymphatics and of the lymph node sinuses, for example, exhibit
a special combination of junctional molecules that usually occur
as physically separated in AJ and TJ [32,33]. Moreover, there is
molecular infidelity regarding the junctional complexes of AJ and
TJ during establishment and maintenance of cell-cell contacts;
ZO-1, for example, may be found in either AJ or TJ or both
[31,34,35]. Furthermore, studies in polarized epithelial cell lines
demonstrated that JAMs, initially identified in TJ, can participate
in the formation of various types of intercellular junctional
complexes [28]. As a consequence, distinct endothelial barrier
functions such as control of vascular permeability and leukocyte
trafficking have been shown to be determined by the organ-
specific molecular architecture of intercellular junctions in blood
and lymphatic vascular endothelium [32,33,36].
Given this variability of intercellular junctions in different
endothelial cell types at different developmental stages and along
the vascular tree and given the inconsistent and incomplete
findings regarding junctions in LSECs, the present study was
designed to comprehensively analyze and clearly define the
molecular composition of intercellular junctional complexes in
LSECs. We show here that LSECs are equipped with complex
junctions of distinct molecular composition and discuss how these
results pertain to the sinusoidal barrier function in liver
development, physiology and disease.
Materials and Methods
Animals
Sprague-Dawley rats were purchased from Janvier (Le Genest-
St-Isle, France) and received humane care according to the
guidelines of the National Institutes of Health (NIH).
Human Tissues
Clinical and histological data of human liver tissue specimens
are shown in Table 1. The tissue was taken at least 5 cm away
from the tumor and was snap-frozen in liquid nitrogen. All human
tissue specimens were provided by the tissue bank of the National
Center for Tumor Diseases (NCT, Heidelberg, Germany) in
accordance to the ethics committee of the University of Heidelberg
(ethics proposal 207/2005).
Table 1. Human patients involved in the study.
Patient Nr Sex Age Diagnosis Pathologic diagnosis of analyzed liver specimens
1 female 59 Colorectal carcinoma with liver metastasis No significant liver pathology
2 male 66 Colorectal carcinoma with liver metastasis No significant liver pathology
3 male 72 Acinar cell carcinoma of the salivary gland
with liver metastasis
No significant liver pathology
4 male 46 Hepatocellular carcinoma (pT2, pN0 (0/2),
Mx, G2);
Complete micronodular liver cirrhosis
5 male 55 Cholangiocarcinoma Moderate liver fibrosis
6 male 64 Hepatocellular carcinoma (pT1, pN0 (0/1),
Mx, G2)
Portal and pericellular liver fibrosis with septa formation
doi:10.1371/journal.pone.0034206.t001
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Rat hepatoma McA-RH7777 cell line was purchased from the
American Type Culture Collection and maintained in Dulbecco’s
Modified Eagle Medium (Invitrogen, Darmstadt, Germany)
supplemented with 10% Fetal Bovine Serum (Biochrom, Berlin,
Germany) and 1% Sodium pyruvate (Sigma, Hamburg, Germany).
Isolation, Purification, and Culture of LSECs and LMECs
Cellswereisolatedandpurifiedasdescribedpreviously[17,19,37].
Briefly, for LSECs isolation the rat liver was perfused via the portal
vein with Collagenase P (Roche Applied Science, Mannheim,
Germany) containing buffer for 8 minutes followed by dissection of
the liver. The organ lysates were cleared from tissue debris by
centrifugationandthencentrifugedat400 gtoyieldacellpellet.The
resuspended cell pellet was then separated on a Percoll (GE
Healthcare, Munich, Germany) density gradient (25%/50%).
Finally the cells found in the interphase of the Percoll gradient were
subjected to MACS sorting with a monoclonal antibody against
stabilin-2andthemonoclonalSE-1antibody.Purityaftersortingwas
confirmedbyFACSwithdirectly-labeledantibodiesagainstStabilin-
2andCD11bresultingin.95%Stabilin-2positive,CD11bnegative
cells. LSECs were plated on collagen-coated dishes and cultured
using a mixture of EBM-2 (Cambrex, Wiesbaden, Germany) and
Willams’ E (Invitrogen, Darmstadt, Germany) growth medium,
containing EGM Single-Quots (Cambrex, Wiesbaden, Germany),
0.2% bovine serum albumin (BSA), 10 ng/mL hepatocyte growth
factor (HGF), and 1% ITS media supplement (Sigma, Hamburg,
Germany) at 37uC in a humidified incubator (5% CO2). For lung
microvascularendothelialcells(LMECs)isolationdissectedratlungs
were digested in Collagenase IV (Worthington, Lakewood, NJ)
solutionandsubjectedtoMACSsortingwithamouseantiratCD31
antibody. Experiments were approved by the animal ethics committee in Baden-Wuerttemberg (Regierungspra ¨sidium Karls-
ruhe AZ:35-9185.82A-35/07).
Table 2. Primary antibodies used in the study.
Antibody Catalog Nr Supplier
anti-VE-cadherin polyclonal rabbit IgG ALX-210-232 Enzo Life Sciences
anti-VE-cadherin monoclonal mouse IgG2a (clone BV9) ab7047 Abcam
anti-VE-cadherin polyclonal goat IgG AF1002 R&D Systems
anti-VE-cadherin polyclonal goat IgG sc-6458 Santa Cruz Biotechnology
anti-VE-cadherin polyclonal rabbit IgG V1514 Sigma
anti-E-cadherin monoclonal mouse IgG2a,k (clone 36/E-Cadherin) 610182 BD Transduction Laboratories
anti-N-cadherin monoclonal mouse IgG1 (clone 32) 610921 BD Transduction Laboratories
anti-a-catenin polyclonal rabbit IgG C2081 Sigma
anti-b-catenin monoclonal mouse IgG1 (clone 14) 610153 BD Transduction Laboratories
anti-p120 catenin monoclonal mouse IgG1 (clone 98/pp120) 610133 BD Transduction Laboratories
anti-plakoglobin monoclonal mouse IgG custom made
anti-JAM-A polyclonal rabbit Ig 36-1700 Invitrogen
anti-Claudin-5 monoclonal mouse IgG1 (clone 4C3C2) 35-2500 Invitrogen
anti-Occludin monoclonal mouse IgG1,k (clone OC-3F10) 33-1500 Invitrogen
anti-ZO-1 polyclonal rabbit Ig 40-2200 Invitrogen
anti-ZO-2 polyclonal rabbit Ig 71-1400 Invitrogen
anti-LYVE-1 polyclonal rabbit Ig 103-PA50 RELIATech
anti-Stabilin-2 monoclonal mouse IgG custom made
anti-human CD32 polyclonal goat IgG AF1330 R&D Systems
doi:10.1371/journal.pone.0034206.t002
Table 3. Primers used in the study.
Primer Name Sequence 59-39
Rn_Cdhn5_F2229 ACGGCTACGAGGGCACAGAGTCCAT
Rn_Cdhn5_R2432 TGCAATGAGATTGGGTCCCCAGGCC
Rn_Cdhn5_F1735 TGGAACCGGCACGCTAACAGTG
Rn_Cdhn5_R2090 ATACTGCTGGCCGGGCATCCAT
Rn_Cdhn2_F380 TGGCGGCCTTGCTTCAGGCATCTCT
Rn_Cdhn2_R602 GCGTACACTGTGCCGTCCTCATCCA
Rn_Cdhn1_F771 AGGCTGGCTGAAAGTGACGCAGCCT
Rn_Cdhn1_R980 ACGGAGGTTCCTGGAAGAGCGCCTT
Rn_Occludin_F1361 ACAGGTGGCGAGTCCTGCGA
Rn_Occludin_R1584 GCAGCAGCCATGTACTCTTCGCTC
Rn_Claudin5_F51 GCACCAGAATCAGCCCCCAACCCA
Rn_Claudin5_R280 AGTCGTCTGCGCCGTCACGATA
Rn_JAMA_F2 CCCAGCGCAGTGGATAGCGA
Rn_JAMA_R219 ACAGGGCAACTTGACAGAGTCGT
Rn_JAMB_F689 AATCCAAAGGGCGGCGCACACAGGA
Rn_JAMB_R919 GCCACACGCAGAAATGACGAAGGCC
Rn_JAMC_F79 TGCTGCTCTTCAGGGGCTGCGTGAT
Rn_JAMC_R301 AACACATCTGTGCGACCGGCCAGGT
Rn_bActin_258_FW GGCACCACACTTTCTACAATGA
Rn_bActin_644_BW TCTCTTTAATGTCACGCACGAT
doi:10.1371/journal.pone.0034206.t003
Junctional Complexes in Liver Endothelium
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e34206Antibodies, Immunofluorescence, and Confocal
Microscopy
Acetone-fixed cryosections and 4%-paraformaldehyde-fixed
cells on coverslips were blocked with 5% BSA, incubated with
first antibodies, followed by appropriate secondary antibodies.
First antibodies are listed in Table 2. Secondary antibodies were
Cy3-, DyLight 488-, DyLight 649- and Cy5-conjugated donkey
anti-rabbit, anti-mouse, or anti-goat IgG (Dianova, Hamburg,
Germany) as well as AlexaFluor 488-coupled anti-mouse and
anti-rabbit IgG (MoBiTec, Go ¨ttingen, Germany). Specimens
were analyzed by laser scanning spectral confocal microscopy
(Leica, Heidelberg, Germany). Excitation and detection wave
lengths were as follows: 488 nm excitation and 518 nm emission
maximum for DyLight 488, 543 nm excitation and 570 nm
emission maximum for Cy3, and 633 nm excitation and 673 nm
emission maximum for DyLight 649 and Cy5. Images were
acquired in a sequential mode. Co-localization analysis was
performed using ImageJ software as described elsewhere [38].
Five different antibodies against independent epitopes of VE-
cadherin (Table 2) were tested in immunohistochemistry of rat
and human liver samples. Immunofluorescent stainings of rat and
human liver samples presented below were performed with anti-
VE-cadherin polyclonal goat IgG (R&D Systems, Wiesbaden,
Germany) and anti-VE-cadherin polyclonal rabbit IgG (Enzo
Life Sciences, Lo ¨rrach, Germany) respectively. The data were
confirmed in at least three independent experiments.
Primer Design, cDNA Synthesis, and PCR
Primers listed in Table 3 were designed using Primer-Blast
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). RNA ex-
traction was carried out using the RNeasy Kit (Qiagen, Hilden,
Germany). After DNase I (Fermentas, St. Leon-Rot, Germany)
pre-treatment, complementary DNA (cDNA) was synthesized
with RevertAid H Minus M-MuLV Reverse Transcriptase
(Fermentas, St. Leon-Rot, Germany). PCR with DFS-Taq DNA
Polymerase (BIORON, Ludwigshafen, Germany) was performed
according to the following program: 95uC for 2 min, followed
by 27 cycles of 95uC for 15 sec, 60uC for 30 sec, 72uC for
60 sec, followed by final elongation at 72uC for 7 min.
Quantitative PCR (qPCR) were performed with M63005P
QPCR System (Agilent Technologies, Santa Clara, CA) in 10 ml
reactions containing 0,8 mM primers, 0,6 ml template DNA, and
Figure 1. VE-cadherin is expressed in liver sinusoidal endothelial cells in rats and humans. (A) Immunofluorescent co-staining of human
liver cryosections with anti-VE-cadherin (green) and anti-CD32b (red) antibodies. (B) Immunofluorescent co-staining of rat liver cryosections with anti-
VE-cadherin (green) and anti-LYVE-1 (red) antibodies. (C) Immunofluorescent co-staining of isolated rat LSECs with anti-VE-cadherin (green) and anti-
Stabilin-2 (red) antibodies. Toto3 (blue) was used to counterstain the cell nuclei. Images were acquired using laser scanning confocal microscopy. Bars
11.9 mm (A, B), 14.14 mm (C). (D) Reverse transcriptase-PCR with mRNA isolated from rat hepatoma McA-RH7777 cell line (1), freshly isolated rat LMECs
(2), and freshly isolated rat LSECs (3). Primers specific for VE-cadherin or b-actin were used.
doi:10.1371/journal.pone.0034206.g001
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Darmstadt, Germany). Cycling conditions were as follows: initial
denaturation at 95uC for 10 min, followed by 50 cycles of 95uC
for 30 sec; 60uC for 1 min. Data were obtained in triplicates for
each sample. Relative gene expression levels were analyzed
using SigmaPlot 11 Software (Systat Software GmbH, Erkrath,
Germany). To test for statistically significant differences in
relative gene expression between LSECs and LMECs, Mann-
Whitney Rank Sum Test was applied.
Results
VE-cadherin is the Major Cadherin Expressed in Rat and
Human LSECs
VE-cadherin expression in human and rat LSECs in situ was
assessed by immunofluorescent analysis of liver cryosections. In
both species, LSECs consistently showed VE-cadherin-positive
immunostaining outlining the wall of the hepatic sinuses. Specific
expression of VE-cadherin in LSECs was confirmed by double-
staining and co-localisation of VE-cadherin using different mono-
as well as polyclonal antibodies in conjunction with established
LSECs markers [18,39] such as CD32b and Lyve-1 (Figure 1A,
1B), as well as stabilin-1 and stabilin-2 (data not shown). VE-
Figure 2. E- and N-cadherin are absent in liver sinusoidal endothelial cells. (A, B) Immunofluorescent co-staining of rat liver cryosections
with anti-E-cadherin (A, green) or anti-N-cadherin (B, green) and anti-LYVE-1 (A, B, red) antibodies. (C, D) Immunofluorescent co-staining of human
liver cryosections with anti-E-cadherin (C, green) or anti-N-cadherin (D, green) and anti-VE-cadherin (C, D, red) antibodies. Images were acquired using
laser scanning confocal microscopy. Bars 14.14 mm (A, B, D), 11.9 mm (C). (E) Reverse transcriptase-PCR with mRNA of freshly isolated rat LSECs.
Primers specific for VE-cadherin (1), E-cadherin (2), N-cadherin (3) or b-actin (4) were used.
doi:10.1371/journal.pone.0034206.g002
Junctional Complexes in Liver Endothelium
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34206cadherin was uniformly expressed in the liver sinusoids across all
hepatic zones (Figure S1). In addition, isolated stabilin-2 positive
rat LSECs kept in culture for 24h displayed prominent VE-
cadherin immunoreactions at the intercellular borders as revealed
by immunofluorescent analysis (Figure 1C). To further confirm
expression of VE-cadherin in LSECs, cDNA of freshly isolated
highly pure rat LSECs was analyzed by reverse transcriptase PCR
(RT-PCR) with two independent sets of primers specific for VE-
cadherin. Both sets of primers showed a similar level of expression
of VE-cadherin mRNA in LSECs as compared to lung
microvascular endothelial cells (LMECs). In contrast, the rat
hepatoma cell line McA-RH7777 used as a negative control did
not contain significant amounts of VE-cadherin (Figure 1D). Thus,
VE-cadherin expression was clearly demonstrated in rat and
human LSECs on the protein and mRNA level.
Rat and human liver sections were also immunostained with
antibodies to N-cadherin and E-cadherin to test whether LSECs
express additional classical cadherins. E-Cadherin was found to be
strongly enriched on the bile canalicular and the lateral cell
membrane of hepatocytes. Only minor E-cadherin-positive immu-
nostainingwasseenalongthespaceofDisseandtherewasminimal,if
any, overlap with Lyve-1- or VE-cadherin-positive LSECs
(Figure2A,2C).N-Cadherinwasdetectedattheintercellularcontact
sites between hepatocytes as well as along the wall of the sinuses
(Figure 2B). As the space of Disse is quite narrow in the rat, N-
cadherin-positive immunoreactions along the sinuses could not be
unequivocallyassignedtohepatocytes,hepaticstellatecellsorLSECs
on tissue sections of rat liver. In the human liver where the space of
Disseoftenappearedwider,therewasonlyincidentalco-localisation
ofN-cadherinwithVE-cadherin(Figure2D).Inaddition, RT-PCR
analysis of freshly isolated LSECs demonstrated strong mRNA
expressionofVE-CadherinandonlyminormRNAexpressionofN-
and E-Cadherin (Figure 2E). Furthermore N-Cadherin expression
was not detectable by immunofluorescent analysis in isolated rat
LSECskept inculturefor 2 h,6 hand24 h(datanot shown).Thus,
VE-Cadherin is the majorAJ-Cadherin inrat and human LSECs.
VE-cadherin co-localizes with Catenins and Zonula
Occludens Proteins in LSECs
When immunofluorescent double labelling analyses were
performed using VE-cadherin antibodies and antibodies against
plaque proteins of AJ known to interact with VE-cadherin, VE-
cadherin was observed to co-localize with a-catenin and b-
catenin in the human liver sinusoids (Figure 3 A and B). Co-
localization of VE-cadherin with a- and b-catenin as well as
with p120-catenin and plakoglobin was also clearly demonstrat-
ed in stabilin-2 and Lyve-1 positive rat LSECs (Figure 4 A-D,
Figure S2). Co-occurrence of VE-cadherin with several AJ
plaque components in rat and human LSECs suggests the
presence of AJ-like protein complexes in LSECs.
Furthermore, triple immunofluorescentanalyseswere performed
with antibodies against the cytoplasmic plaque proteins ZO-1 and
ZO-2 which can occur both at AJ and at TJ, in combination with
antibodies against VE-cadherin and the LSECs marker stabilin-2.
Both,ZO-1andZO-2co-localizedwithVE-cadherininratLSECsin
situ (Figure5 A-B).
Figure 3. a-Catenin and b-Catenin co-localize with VE-cadherin in human LSECs. Immunofluorescent co-staining of human liver
cryosections with anti-VE-cadherin (A, B, green), anti-a-Catenin (A, red), and anti-b-catenin (B, red) antibodies. Images were acquired using laser
scanning confocal microscopy. Bars 11.9 mm.
doi:10.1371/journal.pone.0034206.g003
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Proteins Claudin-5 and Occludin and Enhanced
Expression of JAM-C in LSECs
To address the question whether typical endothelial TJ
molecules are present in LSECs, expression of claudin-5 and
occludin was examined in rat LSECs both on protein and mRNA
levels. By immunofluorescent analysis of rat liver cryosections,
occludin was absent from LYVE-1 positive LSECs, but strongly
expressed at the biliary pole of hepatocytes (Figure 6A). Similarly,
claudin-5 was absent from VE-cadherin positive rat liver sinusoids,
but clearly detectable in endothelial cells of non-sinusoidal hepatic
blood vessels (Figure 6C). To confirm these results, quantitative
RT-PCR (qRT-PCR) for occludin and claudin-5 mRNA was
performed with isolated rat LSECs. Expression of both occludin
and claudin-5 was lower in rat LSECs on mRNA level by 5.7 and
1955 fold respectively as compared to LMECs (Figure 6B and D).
In human liver samples obtained from three patients without liver
fibrosis (Figure 6E) and three patients with liver fibrosis (Figure 6F
and G), the bile canaliculi of hepatocytes were strongly positive for
occludin while the liver sinusoids were not stained with anti-
occludin antibodies. In contrast to rat, human liver sinusoids
displayed heterogenous claudin-5 expression varying among
different patients as well as among different sections analyzed
from the same patient (Figure S3). In contrast to Claudin-5,
however, Occludin was consistently absent and VE-Cadherin was
Figure 4. a-catenin, b-catenin, p120-catenin, and plakoglobin co-localize with VE-cadherin in rat liver sinusoidal endothelial cells.
(A-D) Immunofluorescent co-staining of rat liver cryosections with anti-a-Catenin (A, green), anti-b-Catenin (B, green), anti-p120-Catenin (C, green),
anti-Plakoglobin (D, green), anti-VE -cadherin (A-D, red), anti-Stabilin-2 (A, blue), and anti-LYVE-1 (B-D, blue) antibodies. Images were acquired using
laser scanning confocal microscopy. Bars 11.9 mm.
doi:10.1371/journal.pone.0034206.g004
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with differing degrees of hepatic injury. The heterogeneous
Claudin-5 expression observed here is in line with a detailed
analysis of a larger cohort of patients previously published [26].
JAM-A, -B, and -C are further transmembrane components of
TJ reported to be expressed in endothelium. In rat and human
liver samples, JAM-A co-localized with stabilin-2 (Figure 7A and
B). Furthermore, in rat liver samples, JAM-A was found to co-
localize with VE-cadherin (Figure 7A). Upon qRT-PCR for JAM-
A, JAM-B and JAM-C, equally strong expression of JAM-A was
found in rat LSECs and LMECs (Figure 7C). Interestingly, JAM-B
and -C were overexpressed in rat LSECs on mRNA level by 5.4
and 10.8 fold respectively as compared to LMECs (Figure 7C).
Thus, LSECs are characterized by lack of significant occludin
expression, by a variable Claudin-5 expression and overexpression
of JAM-B and JAM-C.
Discussion
In the present study, we performed a comprehensive analysis
of the molecular composition of the intercellular junctional
complexes of liver sinusoidal endothelium in vivo and in vitro in
two different species, i.e. human and rat. Our results un-
equivocally demonstrate that LSECs assemble the molecular
complexes typical of endothelial AJ clearly disproving the notion
that LSECs lack interendothelial junctions [30]. Similar to
vascular endothelial cells in general, LSECs express the main
transmembrane component of endothelial AJ, i.e. VE-cadherin,
on mRNA and protein level. In freshly isolated rat LSECs, VE-
cadherin is found at the intercellular borders in similar
localization patterns as in other ECs in vitro. Co-localization of
VE-cadherin with a-, b-, and p120-catenins, as well as with
plakoglobin indicates that LSECs form functional AJ complexes
supporting the structural integrity of the sinusoidal vessel wall.
In contrast to most other vascular endothelial cells, the core
endothelial TJ proteins claudin-5 and occludin were absent from
the rat LSECs as assessed in vivo and in vitro and on the protein
and mRNA level. Similarly, human liver sinusoids lacked
occludin expression. However, in human liver samples, we
observed heterogenous claudin-5 immunostaining in LSECs
while non-sinusoidal liver vessels exhibited strong claudin-5
immunoreactivity. Previously, Sakaguchi and colleagues also
demonstrated heterogeneous Claudin-5 expression in tumoral
endothelium of hepatocellular carcinoma and surrounding
LSECs depending on fibrotic grade and tumor differentiation
[26]. Thus the differences in claudin-5 expression between
LSECs of healthy young rats and human livers may be due to
the fact that the human liver samples available for investigation
were derived from older patients that had succumbed to liver
disease. This may have caused capillarization of liver sinusoids
characterized by quantitative and qualitative changes of cell-cell
and cell-matrix adhesion molecules in LSECs [9,15,23,40]. Thus,
plasticity of the LSECs phenotype upon induction of capillariza-
tion may be one possible explanation for the claudin-5
immunoreaction found in human but not in rat liver sinusoids.
Of course, the expression of claudin-5 in human LSECs in situ
may also be due to true species-specific differences. The notion
that claudin-5 and occludin are dispensable for LSECs function
is supported by findings in occludin and claudin-5 knock-out
mice which display normal vascular development, structure and
function in the liver, but show increased vascular permeability in
the cerebral vasculature [41,42].
While lacking some of the typical transmembrane constituents
of endothelial TJ, we show here that LSECs express the zonula
occludens proteins ZO-1 and ZO-2. ZO-1 was first identified as an
intracellular partner of transmembrane components of TJ such as
claudins and occludin, but it has also been found in AJ at the early
stage of establishing endothelial cell-cell contacts when TJ had not
yet been formed [31]. In addition, in cells lacking TJ such as
Figure 5. ZO-1 and ZO-2 localize to VE-cadherin-containing cell-cell junctions in rat liver sinusoidal endothelial cells. (A, B)
Immunofluorescent co-staining of rat liver cryosections with anti-ZO-1 (A, green), anti-ZO-2 (B, green), anti-VE-cadherin (A, B, red), and anti-Stabilin-2
(A, B, blue) antibodies. Images were acquired using laser scanning confocal microscopy. Bars 11.9 mm.
doi:10.1371/journal.pone.0034206.g005
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PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e34206fibroblasts and cardiomyocytes, ZO-1 localized constitutively to
cadherin-containing intercellular junctions, i.e. bona fide adherens
junctions [35]. Furthermore, it has been shown that ZO-1 may
localize to both TJ and AJ concomitantly and is indispensable for
the formation of both types of junctions [34].
In addition, we show here that LSECs express all members of
the family of junctional adhesion molecules, i.e. JAM-A, -B, and –
C which are known to participate in the formation and dynamics
of different types of intercellular contacts [28,43]. In this study, we
do not only show expression of JAM-C in LSECs, but we
demonstrate by using qRT-PCR that JAM-B and JAM-C
expression is much stronger in isolated rat LSECs as compared
to LMECs. This finding may be of potential importance as Orlova
and colleagues have shown that shifting the balance from JAM-A
Figure 6. Immunoflurescent and qRT-PCR analysis of occludin and claudin-5 expression in liver sinusoidal endothelial cells. (A, C)
Immunofluorescent co-staining of rat liver cryosections with anti-Occludin (A, green), anti-Claudin-5 (C, green), and anti-LYVE-1 (A, C, blue) antibodies.
(E) Immunofluorescent staining of a liver sample obtained from the patient 2 with anti-Occludin (green) antibody; BD – bile ducts, S – liver sinusoids.
(F, G) Immunofluorescent co-staining of liver samples obtained from the patients 6 (F) and 4 (G) with anti-VE-cadherin (F, G, green), anti-CD32b (F, G,
red), and anti-Occludin (F, G, blue) antibodies. Images were acquired using laser scanning confocal microscopy. Bars 11.9 mm (A, C), 47.62 mm (E, F),
14.14 mm (G). (B, D) Quantitative reverse transcriptase-PCR with mRNA isolated from rat LSECs and rat LMECs (n indicates the number of samples
analyzed, error bars represent SEM). Primers specific for Occludin (B), Claudin-5 (D), and b-Actin as normalizer were used.
doi:10.1371/journal.pone.0034206.g006
Figure 7. Expression of JAM-family members in liver sinusoidal endothelial cells. (A) Immunofluorescent co-staining of rat liver
cryosections with anti-JAM-A (green), anti-VE-cadherin (red), and anti-Stabilin-2 (blue) antibodies. (B) Immunofluorescent co-staining of human liver
cryosections with anti-JAM-A (green), anti-CD32b (red), and anti-Stabilin-2 (blue) antibodies. Images were acquired using laser scanning confocal
microscopy. Bars 11.9 mm. (C) Quantitative reverse transcriptase-PCR with mRNA isolated from rat LSECs and rat LMECs (n indicates the number of
samples analyzed, error bars represent SEM). Primers specific for JAM-A, JAM-B, JAM-C, and b-Actin as normalizer were used.
doi:10.1371/journal.pone.0034206.g007
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interendothelial adhesion and increases vascular permeability
[36]. Owing to heterophilic interactions between JAM-A, JAM-
B, and JAM-C and the leukocyte integrins LFA-1, VLA-4, and
Mac-1, respectively, JAMs may also contribute to transmigration
of leukocytes and tumor cells through the liver-specific transen-
dothelial barrier established by LSECs. Interestingly, murine heart
endothelial cells have been found to facilitate selective recruitment
of Th1 lymphocytes upon stimulation with TNF-a in contrast to
murine lung endothelial cells [44]. This effect is only partially due
to interactions between VCAM-1 and VLA-4 evoking the
hypothesis that enhanced JAM-C expression in murine heart
endothelial cells could play a decisive role. Thus, JAMs expressed
by LSECs may be involved in the recruitment of specific
subpopulations of lymphocytes as well as of tumor cells to the
liver parenchyma.
Taken together, our data prove the existence of organ-specific
intercellular junctions between endothelial cells of the liver
sinusoids. These junctions contain the full repertoire of proteins
typical of AJ, i.e. VE-cadherin, catenins and plakoglobin, and the
facultative AJ proteins ZO-1 and ZO-2. Interestingly, these AJ
proteins co-occur with the JAM-family members, but not with the
core TJ proteins claudin-5 and occludin. The composition of the
intercellular junctions between LSECs molecularly resembles that
of the intercellular junctions between high endothelial venules
(HEV) representing a site for lymphocyte homing from the blood
to the lymphoid tissues [33]. Nevertheless, the junctions of HEV
EC differ from those of LSECs in their ultrastructure as revealed
by electron microscopy [45,46] indicating so far unrecognized
differences also in the molecular architecture of the junctional
complexes of these two types of endothelial cells. Therefore, it is
well conceivable that the junctions described here represent
a unique kind of mixed-type junction. In summary, the present
study contributes to the currently accumulating knowledge about
cell-type specific intercellular junctions between endothelial cells of
different microvascular beds. The comprehensive molecular
characterization of the specialized intercellular junctions between
LSECs provides a framework for further functional investigations
of the transendothelial barrier of liver sinusoids in numerous
pathological conditions ranging from hepatic inflammation to
formation of liver metastasis.
Supporting Information
Figure S1 The expression of VE-cadherin in rat liver
sinusoidal endothelial cells is not restricted to a partic-
ular hepatic zone. Immunofluorescent co-staining of rat liver
cryosections with anti-VE-cadherin (green), anti-CD32b (red), and
anti-Stabilin-2 (blue) antibodies. Images were acquired using laser
scanning confocal microscopy. Bars 150 mm.
(TIF)
Figure S2 Intensity correlation analysis of co-localiza-
tion of VE-cadherin with a-catenin, b-catenin, p120-
catenin, and plakoglobin in rat liver sinusoids. Merged
confocal images from the Figure 4 are shown along with positive
PDM values (Products of the Differences from the Mean)
calculated for each indicated channel pair.
(TIF)
Figure S3 Heterogenous expression of Claudin-5 in
human liver sinusoids. (A-C) Liver samples obtained from
the patients 4 (A, B) and 6 (C) were co-stained with anti-VE-
cadherin (green), anti-CD32b (red), and anti-Claudin-5 (blue)
antibodies. Images were acquired using laser scanning confocal
microscopy. Bars 56.55 mm (A, B), 47.62 mm (C).
(TIF)
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